Aldeyra Therapeut (ALDX) Misses Q3 EPS by 4c

Aldeyra Therapeut (NASDAQ: ALDX) reported Q3 EPS of ($0.36), $0.04 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Aldeyra Therapeut (ALDX) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• JPMorgan starts FedEx Freight at Overweight on post-spin turnaround
• BMO Capital Starts Carter's (CRI) at Outperform